Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Metastatic NSCLC
Related studies linked through entity extraction aliases.
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
- Status
- RECRUITING
- Phase
- N/A
A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation
- Status
- TERMINATED
- Phase
- PHASE1
Patient's Whole Process Follow-up Management(HOPE-1)
- Status
- RECRUITING
- Phase
- N/A
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients
- Status
- WITHDRAWN
- Phase
- NA
Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
- Status
- RECRUITING
- Phase
- N/A
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2